Dow Up 0.64% Nasdaq Up 0.68%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
11.10 Down 0.20(1.77%) 4:00PM EDT
Prev Close:11.30
Open:11.35
Bid:11.00 x 200
Ask:11.15 x 1000
1y Target Est:17.73
Beta:3.29
Next Earnings Date: 6-Nov-14BCRX Earnings announcement
Day's Range:11.02 - 11.49
52wk Range:4.55 - 14.62
Volume:775,241
Avg Vol (3m):1,255,870
Market Cap:796.49M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BCRX

Comparison

Symbol% ChgMkt Cap
BCRXDown 1.77%796.49M
GSKUp 0.40%113.59B
RHHBYUp 1.43%257.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):45.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.83
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-2.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback